(E)-3-(1H-indol-3-yl)-2-(N-phenylbenzimidazol-2-yl)acrylonitrile

ID: ALA4848866

PubChem CID: 164610506

Max Phase: Preclinical

Molecular Formula: C24H16N4

Molecular Weight: 360.42

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  N#C/C(=C\c1c[nH]c2ccccc12)c1nc2ccccc2n1-c1ccccc1

Standard InChI:  InChI=1S/C24H16N4/c25-15-17(14-18-16-26-21-11-5-4-10-20(18)21)24-27-22-12-6-7-13-23(22)28(24)19-8-2-1-3-9-19/h1-14,16,26H/b17-14+

Standard InChI Key:  GRTKTLFUPXRVLY-SAPNQHFASA-N

Molfile:  

 
     RDKit          2D

 28 32  0  0  0  0  0  0  0  0999 V2000
    6.7189  -24.8775    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4326  -24.4680    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4298  -23.6413    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7171  -23.2319    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0067  -24.4685    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0079  -23.6479    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2276  -23.3902    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.7425  -24.0543    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2256  -24.7196    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.9211  -24.0531    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5136  -23.3406    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0992  -22.6262    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.5115  -24.7643    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6902  -24.7631    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9719  -25.5006    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2035  -25.4332    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4226  -25.1755    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.1694  -25.6676    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9115  -26.4477    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4618  -27.0609    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2691  -26.8887    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5191  -26.1088    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4262  -24.3553    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2052  -24.1071    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3784  -23.3099    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7735  -22.7601    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9927  -23.0131    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8232  -23.8097    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  5  1  1  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  6  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9  5  1  0
  8 10  1  0
 10 11  1  0
 11 12  3  0
 10 13  2  0
 13 14  1  0
  9 15  1  0
 14 24  1  0
 17 16  1  0
 16 14  2  0
 17 23  1  0
 15 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 15  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 23  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4848866

    ---

Associated Targets(Human)

TERT-RPE1 (415 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CAPAN-1 (772 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HCT-116 (91556 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NCI-H460 (60772 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HL-60 (67320 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
K562 (73714 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MM1.S (1111 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Z-138 (387 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 360.42Molecular Weight (Monoisotopic): 360.1375AlogP: 5.57#Rotatable Bonds: 3
Polar Surface Area: 57.40Molecular Species: NEUTRALHBA: 3HBD: 1
#RO5 Violations: 1HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 2.80CX LogP: 5.67CX LogD: 5.67
Aromatic Rings: 5Heavy Atoms: 28QED Weighted: 0.43Np Likeness Score: -1.18

References

1. Perin N, Hok L, Beč A, Persoons L, Vanstreels E, Daelemans D, Vianello R, Hranjec M..  (2021)  N-substituted benzimidazole acrylonitriles as in vitro tubulin polymerization inhibitors: Synthesis, biological activity and computational analysis.,  211  [PMID:33248847] [10.1016/j.ejmech.2020.113003]

Source